case_images: PMC10803402_01
case_images: The fistula is shown before (A) and after (B) antibiotic treatment.
case_images: fmed-10-1322993-g001.jpg
case_images: PMC10803402_01_fmed-10-1322993-g001.jpg
case_images: fig1
case_images: Physical examination revealed no palpable superficial lymph nodes except a local fistula at the distal end of the incision site from her previous left hip surgery (Figure 1A). The fistula was reported to be completely healed during a telephone follow-up in June 2023 (Figure 1B).
case_images: Radionuclide bone imaging. (A) The bone metabolism around the left femoral stem was increased. (B) The blood flow phase was normal. (C) The radioactive uptake in the blood pool phase was increased.
case_images: fmed-10-1322993-g002.jpg
case_images: PMC10803402_01_fmed-10-1322993-g002.jpg
case_images: fig2
case_images: On April 22, whole-body bone scintigraphy (Technetium 99 m-methyl diphosphonate) showed an increased bone metabolism around the stem of the left femoral prosthesis and an increased radionuclide uptake in the blood pool phase, suggesting postoperative chronic infectious lesions (Figure 2).
case_images: MRI of the hip joint. (A) Localized hyperintensity was found in the skin and fascia of the lateral thigh on the left side(T2). (B) The bone and muscle around the left upper femur were hyperintense(T2). (C) Subcutaneous abscess and fistula formed in the upper part of the left thigh.
case_images: fmed-10-1322993-g003.jpg
case_images: PMC10803402_01_fmed-10-1322993-g003.jpg
case_images: fig3
case_images: On April 24, magnetic resonance imaging (MRI) of the left hip joint showed inflammatory exudation around the upper end of the femur and surrounding soft tissue, and a subcutaneous abscess with fistula formation in the upper thigh (Figure 3).
case_images: Timescale of the patient's medical history.
case_images: fmed-10-1322993-g004.jpg
case_images: PMC10803402_01_fmed-10-1322993-g004.jpg
case_images: fig4
case_images: The patient did not experience any side effects of antibiotics or relapse of infection during therapy (Figure 4).